Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy

Journal of Neuroimmunology

Volumn 207, Issue 1-2, 2009, Pages 107-110

  Krystyna, Mitosek Szewczyk ^a   Jacek, Tabarkiewicz ^a   Sebastian, Radej ^a   Ewa, Belniak ^a   Halina, Bartosik Psujek ^a   Zbigniew, Stelmasiak ^a   Jacek, Rolinski ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

B cell; Dendritic cells; Methyloprednisolone; Multiple sclerosis

Indexed keywords

CD123 ANTIGEN; CD19 ANTIBODY; METHYLPREDNISOLONE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION;

ADRENAL CORTEX HORMONES; ADULT; ANTIGENS, CD19; ANTIGENS, SURFACE; B-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INJECTIONS, INTRAVENOUS; LECTINS, C-TYPE; MALE; MEMBRANE GLYCOPROTEINS; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECEPTORS, IMMUNOLOGIC; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 60149091269     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.11.010     Document Type: Article

References (12)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., Gambini C., Mancardi G.L., Uccelli A., and Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U S A. 101 (2004) 11064-11069
3. Duddy M., and Bar-Or A. B-cells in multiple sclerosis. Int. MS. J. 13 (2006) 84-90
4. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., Kim H.J., and Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178 (2007) 6092-6098
5. Kurtzke J.E. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
6. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
7. McDonald W.I., Compston A., Sdan G., Goodkin D., Hartung H.P., Lublin F.D., MaFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., von den Noot S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
8. Navarro J., Aristimuño C., Sánchez-Ramón S., Vigil D., Martínez-Ginés M.L., Fernández-Cruz E., and de Andrés C. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. J. Neuroimmun. 176 (2006) 153-161
9. Nikbin B., Bonab M.M., Khosravi F., and Talebian F. Role of B cells in pathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 79 (2007) 13-42
10. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., and Di Carlo V. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162 (1999) 6473-6481
11. Qin Y., and Duquette P. B-cell immunity in MS. Int. MS. J. 10 (2003) 110-120
12. Qin Y., and van den Noort S. Neuronal and myelin reactive humoral immunity in multiple sclerosis is Th2 dependent. Expert. Rev. Neurother. 7 (2007) 219-220